Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study. (2020)

First Author: Loeff FC
Attributed to:  MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2020.03.957

PubMed Identifier: 32283057

Publication URI: http://europepmc.org/abstract/MED/32283057

Type: Journal Article/Review

Volume: 140

Parent Publication: The Journal of investigative dermatology

Issue: 11

ISSN: 0022-202X